Condition category
Mental and Behavioural Disorders
Date applied
24/10/2005
Date assigned
26/04/2006
Last edited
04/03/2008
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

Contact information

Type

Scientific

Primary contact

Dr Richard Gray

ORCID ID

Contact details

P O Box 30
De Crespigny Park
Denmark Hill
London
SE5 8AF
United Kingdom
+44 (0)207 848 0139
r.gray@iop.kcl.ac.uk

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

N/A

Study information

Scientific title

Acronym

Study hypothesis

Adherence therapy can reduce symptoms, increase attitude and satisfaction towards medication treatment

Ethics approval

Not provided at time of registration

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Hospitals

Trial type

Treatment

Patient information sheet

Condition

Schizophrenia

Intervention

Treatment group: adherence therapy
Control group: treatment as usual such as medication treatment, group counselling, occupational and recreational therapy

Intervention type

Other

Phase

Not Specified

Drug names

Primary outcome measures

Symptoms of schizophrenia measured using the positive and negative syndrome scale

Secondary outcome measures

1. Symptoms of schizophrenia measured using the Global Assessment of Functioning Scale
2. Attitude towards medication measured using the Hogan Drug Attitude Inventory
3. Satisfaction with medication measured using the Satisfaction With Antipsychotic Medication Scale
4. Side effects of medication measured using the Liverpool University Neuroleptic Side Effect Rating Scale

Overall trial start date

01/12/2004

Overall trial end date

31/08/2005

Reason abandoned

Eligibility

Participant inclusion criteria

1. Patients diagnosed by a psychiatrist with schizophrenia according to ICD-10 criteria (World Health Organisation ([WHO], 1992)
2. People with schizophrenia who are older than 20 years of age because they have reached the age of maturity legally and can provide consent independently
3. People with schizophrenia who have been assessed by a psychiatrist not involved in this study to determine that they can provide informed consent
4. People with schizophrenia who are residing in Muang Chiang Mai district

Participant type

Patient

Age group

Adult

Gender

Both

Target number of participants

70

Participant exclusion criteria

Patients suffering from organic brain diseases or learning disability

Recruitment start date

01/12/2004

Recruitment end date

31/08/2005

Locations

Countries of recruitment

Thailand

Trial participating centre

P O Box 30
London
SE5 8AF
United Kingdom

Sponsor information

Organisation

The Royal Thai Government

Sponsor details

Office of Educational Affairs
Royal Thai Embassy
28 Prince's Gate
London
SW7 1QF
United Kingdom
+44 (0)207 584 4538 (5 lines)
enquiries@oeathai.org

Sponsor type

Government

Website

http://www.oeathai.org

Funders

Funder type

Government

Funder name

Praboromarajanok Institute of Workforce Development (Thailand)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

Publication citations

Additional files

Editorial Notes